Candesantan Cilexetil CAS 145040-37-5
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
145040-37-5
Name
Candesantan Cilexetil
Synonyms
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate [ACD/IUPAC Name]
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazol-7-carboxylat [German] [ACD/IUPAC Name]
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl-2-ethoxy-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazol-7-carboxylat [German]
145040-37-5 [RN]
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester [ACD/Index Name]
2-Ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester
2-Éthoxy-1-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French] [ACD/IUPAC Name]
2-éthoxy-1-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1H-benzimidazole-7-carboxylate de 1-{[(cyclohexyloxy)carbonyl]oxy}éthyle [French]
Candesartan cilexetil [JAN] [USAN]
R85M2X0D68
UNII:R85M2X0D68
(±)-1-Hydroxyethyl 2-Ethoxy-1-[p-(o-1H-tetrazol-5-ylphenyl)l]-7-benzimidazolecarboxylate Cyclohexyl Carbonate (Ester)
(2-ethoxy-1-{[4-(2-(1H-1,2,3,4-tetraazol-5-yl)phenyl)phenyl]methyl}benzimidazol-7-ylcarbonyloxy)ethyl cyclohexyloxyformate
[145040-37-5]
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethox
1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2-(2h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-(cyclohexoxycarbonyloxy)ethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-(cyclohexyloxycarbonyloxy)ethyl 1-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)-, hydroxide, inner salt, (±)-
2-?ETHOXY-?1-?[[2′-?(2H-?TETRAZOL-?5-?YL)[1,?1′-?BIPHENYL]-?4-?YL]METHYL]-?1-?[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER-?1H-?BENZIMIDAZOLE-?7-?CARBOXYLIC ACID
2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester-1H-Benzimidazole-7-carboxylic acid
2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-1-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid [ACD/IUPAC Name]
2-Ethoxy-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-Ethoxy-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
7689-03-4 [RN]
Amias [Trade name]
Atacand [Trade name]
Blopress [Trade name]
BR-75900
C077793
Camptothecine
Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
Candesartan celexetil
candesartan cilexetil(?????????)
CANDESARTAN CILEXITIL
DD6672500
H212/91
Kenzen
MFCD00871371 [MDL number]
Parapres
Pharmakon1600-01504261
Racanda
Ratacand [Trade name]
TCV 116 |
TCV116
TCV-116;TCV116;TCV 116;Atacand
TCY 116
TL8000995
Molecular Structure
SMILES
CCOc1nc2cccc(c2n1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5)C(=O)OC(C)OC(=O)OC6CCCCC6
StdInChI
InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
StdInChIKey
GHOSNRCGJFBJIB-UHFFFAOYSA-N
Molecular Formula
C33H34N6O6
Molecular Weight
610.66
MDL Number
MFCD00871371
Safety Data
Symbol
Signal Word
Warning
Hazard Statements
Precautionary Statements
RIDADR
UN 3077 9 / PGIII
WGK Germany
3
Specifications and Other Information of Our Candesantan Cilexetil CAS 145040-37-5
Standard
EP, USP
GMP
CFDA
Basic Patent Situation
US expiry date | 20120604 |
EU expiry date | 20110419 (20120428) |
JP expiry date | 20160428 |
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as Angiotensin II Receptor Antagonist
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/candesantan-cilexetil-cas-145040-37-5/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://watson-int.com/candesantan-cilexetil-cas-145040-37-5/